PRospective Multiple Myeloma Impact Study

Running, not enrolling · Not applicable

Conditions studied: Multiple Myeloma

In brief

This will be a prospective, case-only, study to measure the impact of MMprofiler on treatment intention decisions in Multiple Myeloma patients.

Key facts

Study ID

NCT02911571

Run by

SkylineDx

People needed

250

Starts

2018-02-27

Expected to finish

2026-10-01

Last updated by the study team

2026-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Potentially multiple myeloma according to IMWG criteria
• Candidates for systemic treatment

You may not qualify if…

• ECOG Performance Status > 3
• Tumor sample that fails QA or QC criteria for MMprofiler

Where it is running

• Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia, United States
• Winship Cancer Institute, Emory University — Atlanta, Georgia, United States
• Hackensack University Medical Center — Hackensack, New Jersey, United States
• New York Presbyterian Brooklyn Methodist Hospital — Brooklyn, New York, United States
• Columbia University Medical Center — New York, New York, United States
• Weill Cornell Medicine — New York, New York, United States
• Levine Cancer Institute — Charlotte, North Carolina, United States
• Wake Forest Baptist Medical Center, — Winston-Salem, North Carolina, United States
• Medical College of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.